A dose blocked-randomized, double-blind, placebo-controlled, single and multiple dosing, dose-escalation phase I clinical trial to evaluate the safety, tolerability, pharmacokinetics/pharmacodynamics of KDS2010 and food effect of KDS2010 on bioavailability after oral administration of KDS2010 in healthy young and elderly subjects
100 Clinical Results associated with Neurobiogen
0 Patents (Medical) associated with Neurobiogen
100 Deals associated with Neurobiogen
100 Translational Medicine associated with Neurobiogen